September 23, 2017

Notable Analyst Upgrades and Downgrades for Week of September 18, 2017



Upgrades:


Caterpillar, Inc. (NYSE:CAT) was upgraded by stock analysts at UBS AG from a “neutral” rating to a “buy” rating in a research report issued on Monday. Other analysts have also issued reports about the stock. Wells Fargo & Company reaffirmed an “outperform” rating on shares of Caterpillar in a research report on Wednesday, July 26th. Vetr raised shares of Caterpillar from a “strong sell” rating to a “buy” rating and set a $120.03 price target on the stock in a research report on Thursday, August 10th. Read more …

BP p.l.c. (NYSE:BP) was upgraded by equities research analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating in a note issued to investors on Monday. Several other analysts have also issued reports on BP. BidaskClub raised shares of BP p.l.c. from a “strong sell” rating to a “sell” rating in a research report on Thursday, August 3rd. TheStreet lowered shares of BP p.l.c. from a “b-” rating to a “c” rating in a research report on Thursday, August 10th. Read more …



Gap, Inc. (The) (NYSE:GPS) was upgraded by analysts at Credit Suisse Group from an “underperform” rating to a “neutral” rating in a research note issued on Tuesday, MarketBeat reports. The firm currently has a $30.00 target price on the apparel retailer’s stock, up from their prior target price of $23.00. Credit Suisse Group’s target price would suggest a potential upside of 7.37% from the company’s current price. Read more …




Morgan Stanley upgraded shares of Pfizer, Inc. (NYSE:PFE) from an equal weight rating to an overweight rating in a report published on Wednesday morning. They currently have $39.00 target price on the biopharmaceutical company’s stock, up from their prior target price of $35.00. Other equities research analysts have also issued reports about the stock. Jefferies Group LLC set a $35.00 price target on shares of Pfizer and gave the company a neutral rating in a report on Wednesday, August 2nd. Read more …


Dover Corporation (NYSE:DOV) was upgraded by investment analysts at J P Morgan Chase & Co from a “neutral” rating to an “overweight” rating in a research report issued to clients and investors on Wednesday, MarketBeat.com reports. The brokerage presently has a $105.00 price target on the industrial products company’s stock, up from their prior price target of $80.00. J P Morgan Chase & Co’s target price points to a potential upside of 13.78% from the stock’s previous close. Read more …



Leggett & Platt, Incorporated (NYSE:LEG) was upgraded by investment analysts at SunTrust Banks, Inc. from a “hold” rating to a “buy” rating in a research note issued on Friday, The Fly reports. The analysts noted that the move was a valuation call. A number of other equities analysts have also recently weighed in on LEG. Piper Jaffray Companies initiated coverage on Leggett & Platt, in a report on Monday, June 5th. They issued an “overweight” rating and a $59.00 price target for the company. Read more …

Astrazeneca PLC (NYSE:AZN) was upgraded by research analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating in a note issued to investors on Friday, The Fly reports. AZN has been the topic of a number of other research reports. Piper Jaffray Companies reaffirmed a “buy” rating on shares of Astrazeneca PLC in a research report on Wednesday, August 9th. BidaskClub lowered Astrazeneca PLC from a “hold” rating to a “sell” rating in a research report on Monday, July 24th. Read more …


Downgrades:


Kellogg Company (NYSE:K) was downgraded by investment analysts at Piper Jaffray Companies from an “overweight” rating to a “neutral” rating in a research report issued to clients and investors on Tuesday, MarketBeat reports. They currently have a $78.00 target price on the stock. Piper Jaffray Companies’ price target would suggest a potential upside of 18.42% from the company’s previous close. The analysts wrote, “real threat” to food companies. The firm’s Michael Lavery downgraded Kellogg’s stock rating from Overweight to Neutral with a price target slashed from $78 to $72. Read more …

Wells Fargo & Company lowered shares of Under Armour, Inc. (NYSE:UAA) from a market perform rating to an underperform rating in a research report published on Tuesday morning. They currently have $13.00 price target on the stock, down from their prior price target of $17.00. Other equities analysts also recently issued reports about the company. Vetr downgraded Under Armour from a strong-buy rating to a hold rating and set a $21.02 price objective for the company. in a research report on Monday, July 17th. Read more …


J P Morgan Chase & Co cut shares of 3M Company (NYSE:MMM) from a neutral rating to an underweight rating in a research report sent to investors on Wednesday morning. They currently have $201.00 target price on the conglomerate’s stock, up from their previous target price of $185.00. A number of other equities analysts have also recently issued reports on the company. Royal Bank of Canada reiterated a hold rating and set a $209.00 target price on shares of 3M in a report on Friday, September 15th. Read more …

Hanesbrands Inc. (NYSE:HBI) was downgraded by investment analysts at Instinet from a “buy” rating to a “neutral” rating in a report released on Thursday, Marketbeat reports. They presently have a $26.00 price objective on the textile maker’s stock. Instinet’s target price would indicate a potential upside of 5.52% from the stock’s current price. Several other analysts also recently weighed in on HBI. BidaskClub upgraded Hanesbrands from a “sell” rating to a “hold” rating in a research note on Wednesday, August 9th. Read more …


BofA Merrill has downgraded Ventas (NYSE:VTR) from Buy to Neutral in a report released on 9/22/2017. Yesterday Ventas (NYSE:VTR) traded -1.14% lower at $67.52. The company’s 50-day moving average is $67.37 and its 200-day moving average is $66.32. The last closing price is up 0.64% from the 200-day moving average, compared to the S&P 500 which has increased 0.04% over the same time. 312,552 shares of the stock were exchanged, down from an average trading volume of 1,470,620. Read more …

BofA Merrill has downgraded HCP (NYSE:HCP) from Buy to Neutral in a statement released on 9/22/2017. Having a price of $28.57, HCP (NYSE:HCP) traded -1.19% lower on the day. The last stock close price is down -8.89% from the 200-day moving average, compared to the S&P 500 which has increased 0.04% over the same time. The company has recorded a 50-day moving average of $29.61 and a 200-day moving average of $30.98. 591,576 shares of the stock were exchanged, down from an average trading volume of 3,372,000. Read more …



No comments:

Post a Comment